Chris Ellis is an experienced professional with a strong background in market access, pricing, and contracting within the oncology sector, currently working at Merck since August 2018. Prior roles include positions at Teva Pharmaceuticals focusing on reimbursement strategy in oncology and respiratory biologics, as well as leading marketing initiatives for the severe asthma infusion product CINQAIR. Chris has significant experience in marketing and product strategy from previous roles at Akers Biosciences, Vree Health, and Merck, where contributions led to notable product launches and strategic partnerships. Educational credentials include an MBA in Strategy and Marketing from the University of Michigan and a Bachelor’s degree in Finance from the University of Illinois Urbana-Champaign.
This person is not in the org chart
This person is not in any teams
This person is not in any offices